Annual World Drug Manufacturing Summit

1-3 December 2014, Berlin, Germany

Now in its 13th year, the World Drug Manufacturing Summit provides the key tools to overcome the biggest threats facing pharma manufacturers today.
More info >>

PCI WELCOMES TIM BROWN TO CLINICAL SERVICES GROUP

Philadelphia, PA – July 7th, 2014 - Packaging Coordinators, Inc. (PCI) has announced the addition of Tim Brown to its Global Clinical Services staff, assuming the role of Director of Project Management for North American operations.  Brown is transitioning from PCI’s Commercial Packaging services team at the Rockford site, where PCI operates nine facilities including PCI’s state-of-the-art North American Clinical Packaging, Storage, and Distribution operations.  Brown joins PCI’s Clinical Services team as they are experiencing significant business growth and expansion, evidenced both in personnel growth as well as capital expansions.  In December PCI broke ground on a brand new 97,000 square foot stand-alone Storage and Distribution facility, expected to open in September of 2014.
More info >>

Analysis of Biopharmaceuticals to Conform to ICHQ6B

RSSL

Worldwide, the pharmaceuticals market is anticipated to grow from more than USD 782 billion in 2011 to approach a value of just over USD 971 billion by the end of 2016, registering a CAGR of over 24%. In 2010 the average medicines expenditure per person within the UK was £271, and this is expected to increase with the ageing population. A significant and increasing proportion of these sales are protein-based biotherapeutics or biomolecules. Currently, these account for 19% of the total market, and are growing at twice the rate of traditional small molecule pharmaceuticals. It is predicted that close to 50% of the top 100 pharmaceutical products will be biomolecules by 2016. By far the largest segment of the biopharmaceutical market is the monoclonal antibody (MAb) with an estimated share of 25.6%, which corresponds to USD 51.1 billion.
More info >>